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Malaria has occurred in the Cabo Verde archipelago with epidemic characteristics since its colonization.
Nowadays, it occurs in Santiago Island alone and though prophylaxis is not recommended by the World
Health Organization, studies have highlight the prospect of malaria becoming a serious public health
problem as a result of the presence of antimalarial drug resistance associated with mutations in the parasite
populations and underscore the need for tighter surveillance.
Despite the presumptive weak immune status of the population, severe symptoms of malaria are not
observed and many people present a subclinical course of the disease. No data on the prevalence of sickle-
cell trait and red cell glucose-6-phosphate dehydrogenase deficiency (two classical genetic factors associated
with resistance to severe malaria) were available for the Cabo Verde archipelago and, therefore, we studied
the low morbidity from malaria in relation to the particular genetic characteristics of the human host
population. We also included the analysis of the pyruvate kinase deficiency associated gene, reported as
putatively associated with resistance to the disease.
Allelic frequencies of the polymorphisms examined are closer to European than to African populations and
no malaria selection signatures were found. No association was found between the analyzed human factors
and infection but one result is of high interest: a linkage disequilibrium test revealed an association of distant
loci in the PKLR gene and adjacent regions, only in non-infected individuals. This could mean a more
conserved gene region selected in association to protection against the infection and/or the disease.
© 2009 Elsevier Inc. All rights reserved.
Introduction
According to de Meira et al. [1] epidemic malaria is known to have
occurred in the Cabo Verde archipelago since the remote past . Malaria
should have been introduced in the archipelago during its coloniza-
tion in the XV century. Records from 1507 report that the old
Portuguese sailing ships (caravelas) from the spice route were not
allowed in Cabo Verde ports because of the fear of getting malaria [2].
In 1952, da Costa Monteiro [3] reported malaria as the most serious
public health problem in the archipelago, Santiago being the most
affected island.
Cabo Verde is comprised of 10 islands in the Atlantic Ocean, 500 km
west of Senegal. Santiago is the largest island, where approximately
half of the population resides (capital: Praia). Malaria was almost
eradicated between 1954 and 1970 and since 1973 autochthonous
cases are only observed in this island [4]. The World Health
Organization (WHO) [5] considers there to be a limited risk of malaria
between September and November. There is no recommendation for
prophylaxis but recent studies highlight the prospect of malaria
recurring as a serious public health problem in Cabo Verde and
underscores the need for a closer and continuous surveillance. The
population is considered to be non-immune or semi-immune and
irregular outbreaks occur. An outbreak in 1995–1996 in the St.
Catarina district was followed by parasitological and molecular
analysis during 1 year [6]. Studies indicated thatmalaria is maintained
as asymptomatic and sub-patent infections and that the majority of
the circulating parasite populations harbor chloroquine-resistant
mutations [7].
In the previous two studies, no complicated malaria cases were
found in spite of high parasitaemias. Most of patent parasitaemias
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were above the range of 1000–10,000 parasites/μl, usually considered
a cut-off level for malaria attacks [8]. However, individuals of all ages
presented no more than mild symptoms such as fever, headache,
nausea and general malaise. This population seemed not to develop
severe symptoms of malaria despite its presumptive weak immune
status and many persons exhibit a subclinical course. The low
morbidity associated with malaria infections in this island may be
related to factors of both parasites and host, which may control the
severity of the malaria infection.
In the localized outbreak in St. Catarina district [6], we suggest that
the genetically homogeneous circulating parasite population could
have been a weakly virulent parasite. However, when different
localities were studied [7] and Plasmodium falciparum heterogeneity
was observed this hypothesis proved untenable. Therefore, no
evidence is available regarding the contribution of parasite factors
to the low morbidity observed in the island.
The establishment of clinical symptoms could be attenuated due to
premunition, already described for other areas of unstable and low-
level transmission of malaria [9,10,11]. Also, differences in clinical
consequences of infection with P. falciparum as consequence of host
factors have already been demonstrated [12,13] and the most
common and best characterized protective polymorphisms are
those involving the erythrocyte-specific proteins and enzymes, such
as hemoglobin (Hb) and glucose-6-phosphate dehydrogenase (G6PD)
variants.
Questioning if the observed lowmorbidity in Santiago Island could
be a consequence of particular characteristics of the host population
and since no data on the frequency of these human genetic
polymorphisms are available for the Cabo Verde archipelago we
studied the prevalence of HbS allele responsible for the sickle-cell trait
(heterozygosity for the HbS mutation in β-globin gene, Hb β globin)
and the prevalence of G6PD variants, two classical genetic factors
strongly associated to resistance against human severe malaria.
Further, both may have a crucial importance in the control and
management of malaria cases. Malaria can be one of the major causes
of hospitalization and death in patients with sickle cell anemia and as
a result, antimalarial prophylaxis is included in the standard
management of patients with the disease. However, with the spread
of chloroquine resistance there is an on-going debate on which drugs
should now be used [14]. Concerning G6PD deficiency, the epidemic
conditions of P. falciparum malaria justify the use of primaquine as a
gametocidal drug but this drug presents potentially fatal side effects
in G6PD-deficient individuals [15].
In sub-Saharan Africa, X-linked G6PD is essentially a tri-allelic
polymorphism: G6PDB, the most common allele associated to normal
enzymatic activity; G6PDA, which results in approximately 85% of the
normal enzymatic activity and the G6PDA− deficiency allele, which
implies only around 12% of normal enzymatic activity with a range of
5–25% in sub-Saharan Africa [16,17]. However, considering the
history of Cabo Verde settlement and the reported high European
contribution, [18] we also searched for the G6PD Mediterranean
(Med) variant, the most common in countries surrounding the
Mediterranean Sea [19]. This variant is associated with 3% of normal
enzyme activity and usually ranges in frequency from 2% to 20% in
Europe [20].
More recently, pyruvate kinase (PK) deficiency was associated
with resistance to the disease in rodent models [21] and humans
[22,23]. Up to now, elevated frequencies of pyruvate kinase liver and
red cells (PKLR)-deficient alleles have not been recorded in areas
endemic for malaria, although a systematic analysis has not been
done. The information about the frequency of PK deficiency in African
populations is clearly limited [24,25]. We, therefore, included its
analysis in this study. The PKLR gene (1q21) encodes for either PK-L
(in liver) or PK-R (in red cells), according to the use of tissue-specific
promoters (leading to structural differences in the protein N-terminal
region). The coding region is split into 12 exons, 10 of which are
shared by the 2 isoforms, while exons 1 and 2 are specific for the
erythrocyte and hepatic isozyme, respectively. About 180 mutations
associated with PK-deficiency and 8 polymorphic sites have been
reported in the PKLR gene [26].
Materials and methods
Study area and Isolates
Biological material–DNA samples obtained from blood–was
already available for this analysis. Samples were collected in localities
from different Districts of Santiago Island (Praia—south, St Catarina—
west, St Cruz—east and Tarrafal—north) in 1995–1996 [6], 1998–2000
and 2003 [7]. From a total of 1056 available samples, a sub-sample of
257 unrelated individuals was used for the present study (99
individuals from Praia, 23 from St Cruz, 119 from St Catarina and 16
from Tarrafal).
Individual data such as gender, age, and malaria history were
available. Further, given that each individual was well characterized
for Plasmodium-infection (species and genotype) and clinical status
(most of them asymptomatic and a few with mild symptoms), two
groups were defined: 64 infected (I—presence of infection at least
once during the collections period) and 188 non-infected (NI—
absence of infection throughout the collection period); infection
status was uncertain in 5 individuals.
For the analysis of PK polymorphisms, two additional groups were
also analyzed–80 adult healthy Portuguese individuals–PT-C (DNA
prepared from finger-prick blood samples collected in 2006 at Health
Centre of Coruche, Portugal as described in [27]) and 21 Portuguese
individuals with hereditary nonspherocytic hemolytic anemia
(HNSHA) caused by PK-deficiency—PT-PKD (DNA prepared from
venous blood samples). These PK-deficient individuals were previ-
ously diagnosed by PK enzyme assay and molecular genetic analysis
[28,29].
The investigation was approved by the Ministry of Health of Cabo
Verde and by the Ethical Committee at institutions involved in the
study. Each person (or parent) was informed of the nature and aims of
the study and told that participation was voluntary.
Detection of hemoglobin S allele (HbS)
The mutation at c.6 of the β globin gene was detected using an
adaptation of the technique described byWaterfall and Cobb [30] and
the homozygous HbSS status was confirmed by a PCR-RFLP technique
(details as Supplementary Material).
Detection of glucose-6-phosphate dehydrogenase polymorphisms
Mutations in the G6PD gene were detected by a PCR-RFLP method
as described in Tishkoff et al. [20] (details as SupplementaryMaterial).
The possible nine genotypes were grouped as follows: hemizygous
males G6PDB and G6PDA, homozygous females G6PDBB and G6PDAA
and heterozygous females G6PDBA (variants with a putative normal
enzyme activity) as g6pd+; hemizygous males G6PDA− and homo-
zygous females G6PDA−A− (putative deficient variants) as g6pd- and
heterozygous females G6PDBA− and G6PDAA− (variants with a
putative intermediate enzyme activity) as g6pd± [31].
Detection of pyruvate kinase polymorphisms
Analysis of PKLR gene was done by two approaches: (1) typing of
polymorphic loci and searching for relevant mutations associated to
PK-deficiency previously described and (2) search for new micro-
satellite regions—short tandem repeats (STRs) in the gene and
adjacent regions. In total, a PKLR gene spanning region of 95 kb was
analyzed.
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Analysis of binary polymorphisms
Two mutations were investigated: 269TNA (90IleNAsn) at exon 3,
the mutation identified in mice as associated to malaria protection
[21], and already described in PK-deficient individuals [32] (technical
details as Supplementary Material) and 1456CNT (486ArgNTrp) at
exon 11, the most common mutation responsible for PK deficiency in
humans from Portugal and some Sub-Saharan regions [33,34,35].
Also, two polymorphisms were analyzed: the single nucleotide
polymorphism (SNP) 1705A/C at exon 12 [35,36,] and the T10/19
repeat at intron 10 [37], common polymorphic sites in São Tomé e
Príncipe [24].
Analysis of STRs
After searching for STRs in the PKLR gene (accession nr AY316591)
and downstream/upstream adjacent regions (accession nr AL713999),
4 loci were chosen for analysis: 2 inside (intron 3-IVS3 and intron
11-IVS11) and 2 downstream the gene (25 kb—locus PKA and 65 kb
—PKV). IVS11 was the only one already described as polymorphic
[38] (see Supplementary Material for amplification conditions and
analysis of PCR products).
Statistical analysis
Pearson χ2 test was used for comparison of populations from
different districts and malaria I and NI groups. Additionally, PK
polymorphisms were also compared with the two Portuguese groups,
PT-C and PT-PKD. Allelic frequencies and selection signatures were
investigated (genetic diversity, Hardy–Weinberg equilibrium devia-
tion and linkage disequilibrium) with Arlequin 3.11. for Windows
[39]. For all tests, a significance level of 0.05 was considered.
Results
Hemoglobin polymorphisms
The β globin genotype was successfully defined for a total of 217
individuals (84%). From these, 92% were HbAA, 7% HbAS and 1% HbSS.
HbS allele was only found in Praia (11% of HbAS) and St Catarina (4%
of HbAS and 3% of HbSS) districts with a very low frequency (0.05).
I and NI individuals distributed similarly among HbAA and HbAS
genotypes [21% I and 79% NI in the HbAA group (unknown infection
status of 3 individuals) and 23% I and 77% NI in the HbAS group
(unknown infection status of 1 individual)]. All 3 HbSS individuals
were I.
Glucose-6-phosphate dehydrogenase polymorphisms
G6PD genotype was measured in a total of 176 (68%) individuals,
77 males and 99 females. Seventy-four percent of males presented
G6PDB genotype, 25% G6PDA and 1% G6PDA−; 61% of females
presented G6PDBB genotype, 29% G6PDBA, 6% G6PDAA and 4%
G6PDAA− (no genotypes G6PDBA− and G6PDA−A− were found).
In the total population, allelic frequencies were f(B)=0.95, f(A)=
0.04 and f(A−)=0.008, respectively but A− allele was only found in
Praia and Tarrafal districts, being much more frequent in the latter—
0.019 and 0.115, respectively (P=0.007), which reflected the
presence of 3 G6PDAA− genotypes. G6PDMed variant was not found.
Ninety-seven percent of individuals were G6PD+, 2% were G6PD±
and 1%were G6PD-. Normal condition seems to be equally prevalent in
both genders (99% G6PD+ in males and 96% in females); 1% and 0% of
G6PD- in males and females, respectively and 4% of G6PD± in females.
Among A− carriers, all except one G6PDAA− female were NI. I and
NI individuals distributed similarly among G6PD+ and G6PD± groups
[33% I and 64% NI in the G6PD+ group (unknown infection status of 5
individuals) and 25% I and 75% NI in the G6PD± group]. The only
G6PD-individual was NI.
Pyruvate kinase polymorphisms
Binary polymorphisms
The 269TNA (exon 3) and 1456CNT (exon 11) mutations were
screened with success in 253 (98%) and 255 (98%) individuals
respectively and mutated alleles were not found.
Polymorphisms 1705A/C (exon 12) and T10/19 (intron 10) were
accomplished in a total of 200 individuals (78%). Regarding 1705A/C,
19.5% were of AA genotype, 33% CC and 47.5% AC. Allelic frequencies
were f(A)=0.43 and f(C)=0.57. Regarding (T)10/19, 27% were of
10/10 genotype, 20.5% 19/19 and 52.5% 10/19. Allelic frequencies
were determined to be fT(10)=0.53 and fT(19)=0.47. The analysis
of possible haplotypes revealed that 1705C/(T)10 exhibited a
frequency of 0.52 and 1705A/(T)19 a frequency of 0.42. The other
two, 1705A/(T)10 and 1705C/(T)19, presented very low frequencies
(0.01 and 0.05, respectively).
FST values were calculated for all pairs of districts and only St
Catarina and St Cruz revealed significant differences (P=0.045±
0.02). Concerning both 1705A/C and (T)10/19 allelic frequencies,
while St Catarina follows the general trend [f(A)=0.41 and f(C)=
0.59; f(T)10=0.54 and f(T)19=0.46], in St Cruz values are inverted
[f(A)=0.57 and f(C)=0.43; f(T)10=0.39 and f(T)19=0.61].
Haplotype frequencies were also different in St Cruz—on the
opposite to the general population, 1705A/(T)19 was the predom-
inant haplotype with a frequency of 0.57, followed by 1705C/(T)10
with 0.39; 1705C/(T)19 was present with a frequency of 0.05 and
1705A/(T)10 was absent.
In total population, no significant differences were found between
I and NI. However, when districts were compared separately, certain
differences were found in St Catarina as regards locus (T)10/19—the
group of I individuals showed a significantly higher heterozygosity
than expected (P=0.009) and allelic frequencies were inverted
comparing to the general trend [fT(10)=0.48 and fT(19)=0.52] in
the NI. Regarding haplotypes, in the NI group, both 1705C/(T)10 and
1705A/(T)19 showed similar frequencies (0.47 and 0.45, respective-
ly) and 1705C/(T)19 showed higher frequency than in the other
groups (0.07).
STRs
The 4 STR loci in the PKLR gene and downstream adjacent region–
IVS3 (intron 3), IVS11 (intron 11), PKA (25 kb downstream) and PKV
(65 kb downstream) (Fig. 1)–were screened in 252 individuals (98%).
All STRs were confirmed to be polymorphic with variable number
of repeats—the number of (ATT) repeats in the IVS11 locus varied
between 7 and 18, the number of (AAAT) repeats in the PKA locus
varied between 6 and 21 and the number of (TTTA) repeats in the PKV
locus varied between 8 and 13. The IVS3 locus is themost polymorphic
with 8 repeat regions and it is interrupted. The consensus sequence
determined, allele classification, etc. are presented as Supplementary
Material. The number of repeats in this locus varied between 27 and
43.2, which were nomenclature as alleles 1 to 26.
In the overall population of Cabo Verde, IVS3 locus presented the
greatest diversity indices with the larger allele number and expected
heterozygosity (Table 1). Observed heterozygosity was according to
Hardy–Weinberg expected frequencies for all loci, except for IVS3,
which it is significantly below the expected (P=0.000). All pairs of
loci revealed a marked Linkage Disequilibrium (LD) (P=0.000), i.e. a
significant LD for a ≈75 kbp spanning region (IVS3 was not
considered as it was not in Hardy–Weinberg equilibrium).
When districts were compared and FST values calculated, signif-
icant values were obtained for all pairs including St Cruz (vs. Praia—
0.012, P=0.018; vs. St Catarina—0.015, P=0.009; vs. Tarrafal—0.012,
P=0.045). All the other three revealed no differences between each
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other. No conspicuous differences seemed to exist regarding allelic
frequencies or inferred haplotypes except that it is the only district
when IVS3 observed heterozygosity was according to Hardy–Wein-
berg expected frequencies.
Regarding the studied Portuguese groups—PT-C and PT-PKD, IVS3
locus also presented the greatest diversity indices with the larger
allele number and expected heterozygosity (Table 2). Observed
heterozygosity was according to Hardy–Weinberg expected frequen-
cies for all loci in the PT-C but not in PT-PKD. In this one, both IVS3 and
IVS11 were significantly below the expected (P=0.000 and
P=0.002, respectively). Again excluding IVS3 from the analysis, PT-
C only showed LD for the closer loci (PKV/PKA and PKA/IVS11), while
PT-PKD just had LD for PKV/IVS11 but since this latter, as IVS3, was
not in Hardy–Weinberg equilibrium, we may say that no LD was
observed between loci in this group.
When FST values were calculated for the two Portuguese groups, a
significant value was obtained (0.025, P=0.009). When those were
calculated for all the studied populations pairs, significant values
(P=0.000) were obtained for all: CV-Total vs. PT-C—0.068 and vs. PT-
PKD—0.111; CV-St Cruz vs. PT-C—0.111 and vs. PT-PKD—0.170; CV-I-
St Catarina vs. PT-C—0.076 and vs. PT-PKD—0.122; CV-NI-St Catarina
vs. PT-C—0.076 and vs. PT-PKD—0.124.
When groups of I and NI were analyzed separately, lower number
of alleles was observed in I for all loci (IVS3: I—20, NI—25; IVS11: I—9,
NI—11; PKA:I—10, NI—11) except for PKV (5 alleles in both groups)
but this may be due to the smaller sample size of the I group (I—128,
NI—376 alleles). Calculation of FST revealed no significant differences
between the groups, both presenting the same most frequent alleles
for all loci and no specific haplotypes being associated to any of them.
Yet, LD analysis revealed different results. While in the NI, as in
overall population, a marked LD was observed between all pair of loci,
in the I this effect was not found between the most distant loci—IVS11
and PKV. This could also be related with the smaller sample size of the
I group, as it also happened in those districts with smaller sample size
when were analyzed separately (St Cruz—46 alleles and Tarrafal—32
alleles). However, when I and NI from St Catarina, which have similar
sample sizes (I—112 alleles and NI—118), were compared, the same
was observed—a marked LD between all pair of loci in the overall
population and NI alone and no linkage between IVS11 and PKV in the
I. Besides, I and NI from St Catarina revealed no significant differences
between them but IVS3 observed heterozygosity was according to
Hardy–Weinberg expected frequencies in the I group.
Discussion
The study of malaria epidemiology is crucial for control, especially
in countries like Cabo Verde where mosquito vectors are in close
proximity to susceptible host populations and tourists. In Cabo Verde,
we are addressing the three biological entities involved in the
complex malaria life-cycle doing both parasitological [6,7] and
entomological studies (on-going). The present study addresses
some human host genetic polymorphisms in association to malaria.
Sickle cell disease affects millions of people worldwide and it is
most common among people whose ancestors come from sub-
Saharan Africa, India, Saudi Arabia and Mediterranean countries.
Frequencies of the heterozygous state for the sickle cell gene (HbAS)
range from 2% to 38% in sub-Saharan Africa where HbS allele
frequencies frequently exceed 25% [14,16,40]. Sickle-cell trait is the
best described host-specific factor shown to confer strong protection
against P. falciparum in numerous studies over the course of the last
50 years [41,42,43,44].
Deficient G6PD alleles are distributed worldwide with a global
prevalence of deficiency of 4.9% and an estimate of nearly 330 million
people carrying a deficiency-associated mutation in the G6PD gene
Fig. 1. The 95-kbp fragment analyzed, including PKLR gene and flanking regions. (a) Localization in chromosome 1q21; (b) localization of all mutations and polymorphisms (269TNA,
1456CNT, 1705A/C, (T)10/19, PKV, PKA, IVS11 and IVS3) genotyped in the present study.
Table 1
Diversity indices for the studied short tandem repeats in the Cabo Verde population.
Loci Number of alleles Heterozygosity
Observed Expected P-value
IVS3 26 0.825 0.927 0.000
IVS11 11 0.873 0.850 0.458
PKA 11 0.766 0.804 0.256
PKV 6 0.619 0.640 0.404
Table 2
Diversity indices for the studied short tandem repeats in the Portuguese groups.
Loci PT-C PT-PKD
Number
of alleles
Heterozygosity Number
of alleles
Heterozygosity
Obs Exp P Obs Exp P
IVS3 19 0.913 0.906 0.389 11 0.524 0.792 0.000
IVS11 9 0.738 0.682 0.636 5 0.476 0.708 0.002
PKA 8 0.488 0.512 0.162 4 0.143 0.139 1.000
PKV 5 0.588 0.601 0.697 4 0.476 0.580 0.294
PT-C: Portuguese healthy individuals; PT-PKD: Portuguese individuals with hereditary
nonspherocytic hemolytic anemia (HNSHA) caused by PK-deficiency; Obs: Observed
Heterozygosity; Exp: Expected Heterozygosity; P: P-value.
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[45]. The highest prevalence is reported in Africa, southern Europe,
the Middle East, Southeast Asia, and the central and southern Pacific
islands; however, because of fairly recent migration, deficient alleles
are nowadays quite prevalent in North and South America and in parts
of northern Europe [19]. In most areas of high prevalence of G6PD
deficiency, several polymorphic alleles are found but tropical regions
of Africa are one exception, where the variant G6PD A− accounts for
about 90% of G6PD deficiency with frequencies of 5–25% [16,17]. The
coincident worldwide distribution of malaria and mutated G6PD
alleles made “The malaria/G6PD hypothesis” generally accepted [46].
Further evidence of protection against severe P falciparum malaria
comes from both epidemiological studies [47] as well as from in vitro
work [48,49].
PK deficiency along with G6PD deficiency, are the two most
frequent enzyme disorders causing chronic hemolytic anemia
worldwide. In families with no consanguinity, PK-deficient indivi-
duals are usually compound heterozygotes and prevalence of
heterozygous individuals is estimated to be 1–2% in most studies
[50]. The highest frequencies of the PK deficiency associated alleles
are found in Europe and Asia with a prevalence ranging from 1% to
3.6% [26,33]. As these regions were historically endemic for malaria, it
could have been responsible for maintaining this frequency or the
∼180 mutations resulting in PK-deficiency are simply the product of
random variation or other population genetic phenomena. However,
in Africa, although the prevalence of PK deficiency is not known, the
perception exists that it is rare, whichmay reflect a lack of testing [23].
If the marked in vitro protective effect of homozygosity for PK
deficiency against malaria translates into the field (further supported
by themurinemodel data), the argument that malaria hasmaintained
the polymorphic frequency of the abnormal alleles may be plausible.
In addition, the large number of PKLR mutations per se also suggests
that these have been maintained by a selective force [23].
In the present study of the β globin chain of Hb, 6% of HbAS
individuals and a frequency 0.05 of HbS allele are low values for a sub-
Saharan region. Also G6PD deficiency associatedmutations occurs in a
very low frequency in this population (0.6%). Concerning PKLR
polymorphisms, frequencies of alleles or haplotypes also differ from
those described for African populations. Allelic frequencies of
polymorphism 1705A/C [f(A)=43%, f(C)=57%] are closer to the
European populations [f(A)∼29%, f(C)∼71%] than to Saharawi
population from North Africa [f(A)∼62%, f(C)∼38%] or sub-Saharan
populations [f(A)∼67%, f(C)∼33%] [25]. Allelic frequencies of the
repeat (T)10/19 [f(10)=53%, f(C)=47%] are closer to the Portuguese
population [f(10)∼78%, f(19)∼22%] than to São Tomé e Príncipe (Gulf
of Guinea, West Africa) [f(10)∼36%, f(19)∼64%] [24]. Allelic frequen-
cies of all these polymorphisms seem always be closer to the
European, particularly to the Portuguese populations. The most
frequent haplotypes 1705C/(T)10 and 1705A/(T)19, were the only
two observed in Portugal and Central Europe [37]. However, the other
two, 1705A/(T)10 and 1705C/(T)19 also occurred in low frequencies.
As in São Tomé e Príncipe [24], there is a strong but not total
association for combinations among these two biallelic systems.
Such low frequencies of traits HbS and G6PDMED are somehow
unexpected. It could be due to the already well known importance of
Caucasian admixture in the population of Cabo Verde [18] but these
traits are quite prevalent in the Mediterranean region, an endemic
region for malaria in the past. Further, Santiago Island should have
had less contribution from Caucasians as demonstrated before in
previous studies with mtDNA [51], Y-chromosome lineages [52] and
autosomal STR [53].
Nevertheless, particular settlements with a strong African contri-
bution to the genetic composition of the population seemed to persist
as it may be the case of St Cruz. This district located in the east coast of
the island showed FST values significantly different with all other
studied populations both considering loci 1705A/C and (T)10/19 or
STRs analysis. Moreover, allelic frequencies of the first two loci [f(A)
=57%, f(C)=43%; fT(10)=39%, fT(19)=61%] were closer to the
Saharawi population from North Africa and São Tomé e Príncipe (see
above). Althoughwe do not have historical reports about St Cruz or its
capital Pedra Badejo (former Port of São Tiago), it is commonly said
that the escaping slaves (Cabo Verde became an important provi-
sioning station for slaves headed for the Americas) used to hide in this
area, from where they could escape to the Island of Maio. This could
justify such a stronger African contribution for the genetic background
of this population but this should be further analyzed with more
balanced sample sizes.
In the present study, nomalaria related clinical data were available
but regarding the infection status no association seems to occur with
either the Hb β globin or the G6PD genotype. Also no haplotype or
polymorphism of PKLR gene was associated to infected or non-
infected individuals. Nevertheless some striking results related with
PKLR analysis deserve a special remark. A linkage disequilibrium test
revealed an association of distant loci only in non-infected individuals.
This could mean a more conserved gene region in these individuals,
which could happen if it would confer any protection against the
infection and/or disease. Further, other peculiarities were found in
the two groups. Infected individuals from St Catarina showed a
significantly higher heterozygosity than expected in the locus T10/19
and on the opposite, it was the only group where IVS3 observed
heterozygosity was within Hardy–Weinberg expected frequencies.
Non-infected individuals from this district showed inverted allelic
frequencies of the locus T10/19 comparing to the general trend and
haplotypes 1705C/T10 and 1705A/T19 presented similar frequencies
and 1705C/T19 showed higher frequency than in other studied
groups. Further studies are needed to assess if these findings have a
real biological meaning or are simply sampling artifacts.
Concluding remarks
This was the first study where data on sickle cell trait and G6PD
deficiency frequencieswereobtained forCaboVerdehumanpopulations.
In this study no association was found between the analyzed
human genetic factors and infection status of individuals. Three main
reasons may have contributed for this: (1) the role of erythrocyte
polymorphisms are usually associated and much easier demonstrated
in severe than in mild or asymptomatic cases [54], (2) the cross-
sectional sampling makes the infected/non-infected classification a
faint case definition for an association study and 3) selective pressure
of malaria, even if it had occurred, could never had a strong effect in
this area due to its epidemic character.
Nonetheless, the finding of a very low frequency of G6PD
deficiency associated alleles (A− and MED) have important implica-
tions for the malaria control strategies defined by the National
Program to Fight against Malaria (Programa Nacional de Luta contra o
Paludismo, PNLP) viewing that it is recommended by WHO [55] that
primaquine (potentially lethal in G6PD-deficient individuals) should
be added to the drug regimen to block transmission in epidemic
conditions such as Cabo Verde.
Regarding the PKLR gene, responsible for PK deficiency, recently
reported as conferring protection againstmalaria in rodent and in vitro
models, this study has not shown any clear association with malaria
infection. Selective advantage afforded individuals protection from
severe life-threatening complications of malaria and did not neces-
sarily decrease their susceptibility to infection. Further, pyruvate
kinase deficiency is a heterogeneous condition andmost of the clinical
phenotypes are mild or moderate in severity [26]. This suggests that
the reproductive cost of PK deficiencywas not limiting andmutations/
polymorphisms would be spread in apparently healthy individuals.
Nevertheless, this is, to our knowledge, the first genetic
population study about this putative association and results such
as the region in linkage identified in the non-infected group deserve
further investigation. Also, to further assess the assumption of a
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protective effect of PK deficiency, further studies are being
performed in other African populations from malaria highly
endemic areas with well-defined malaria clinical cases (different
severity level), well-characterized Plasmodium-infection and Hb β
globin and G6PD status (to control for negative epistasis) and
immediate enzymatic activity dosage at collection.
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